Dipesh Uprety, Assistant Professor of Thoracic Oncology at the Barbara Ann Karmanos Cancer Institute, shared a post on LinkedIn:
“Pleased to share our study ‘Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and Outcomes‘
In this retrospective analysis of 8,809 tumor samples with CUP, molecular profiling revealed a high prevalence of actionable biomarkers in CUP and was associated with improved survival with biomarker-guided therapy.”
Other articles about Metastatic Carcinoma on OncoDaily.